Oral health in oncology: impact of immunotherapy
详细信息 查看全文
- 作者：Leanne K. Jackson (1) (4) <br> Douglas B. Johnson (1) <br> Jeffrey A. Sosman (1) <br> Barbara A. Murphy (1) <br> Joel B. Epstein (2) (3) <br>
- 刊名：Supportive Care in Cancer
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：23
- 期：1
- 页码：1-3
- 全文大小：96 KB
- 参考文献：1. Hodi FS, O'Day SJ, McDermott DF (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711鈥?23 blank" title="It opens in new window">CrossRef <br> 2. Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455鈥?465 blank" title="It opens in new window">CrossRef <br> 3. Fecher LA, Agarwala SS, Hodi FS, Weber JS (2013) Ipilimumab and its toxicities: a multidisciplinary approach. Oncologist 18:733鈥?43 blank" title="It opens in new window">CrossRef <br> 4. Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443鈥?454 blank" title="It opens in new window">CrossRef <br> 5. Topalian SL, Sznol M, McDermott DF, et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014. <br> 6. Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. The New England Journal of Medicine 2013. <br> 7. Du GH, Qin XP, Li Q, Zhou YM, Shen XM, Tang GY (2011) The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells. J Oral Pathol Med 40:525鈥?32 blank" title="It opens in new window">CrossRef <br> 8. Schubert MM, Correa ME. Oral graft-versus-host disease. Dental clinics of North America 2008;52:79鈥?09, viii-ix. <br> 9. Deboni AL, Giordani AJ, Lopes NN (2012) Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer. Supportive care in cancer. Off J Multinatl Assoc Support Care Cancer 20:2903鈥?911 blank" title="It opens in new window">CrossRef <br> 10. Pekiner FN, Demirel GY, Borahan MO, Ozbayrak S (2012) Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus. J Oral Pathol Med 41:484鈥?89 blank" title="It opens in new window">CrossRef <br> 11. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus鈥攁 review. J Oral Pathol Med 39:729鈥?34 blank" title="It opens in new window">CrossRef <br> 12. Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 2010;52:163鈥?06. <br> 13. Houshmand B, Rafiei A, Hajilooi M (2012) Influence of cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in periodontitis. Arch Oral Biol 57:1218鈥?224 bio.2012.03.002" target="_blank" title="It opens in new window">CrossRef <br> 14. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA (2000) Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164:2102鈥?109 blank" title="It opens in new window">CrossRef <br> 15. Gildener-Leapman N, Ferris RL, Bauman JE (2013) Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol 49:1089鈥?096 blank" title="It opens in new window">CrossRef <br> 16. Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC (1995) Oral and dental management of the cancer patient: prevention and treatment of complications. Supportive care in cancer. Off J Multinatl Assoc Support Care in Cancer 3:168鈥?75 blank" title="It opens in new window">CrossRef <br> 17. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC (2008) Oral graft-versus-host disease. Oral Dis 14:396鈥?12 blank" title="It opens in new window">CrossRef <br> 18. Sanchez AR, Sheridan PJ, Rogers RS (2004) Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. J Periodontol 75:613鈥?19 blank" title="It opens in new window">CrossRef <br> 19. Furness S, Bryan G, McMillan R, Worthington HV (2013) Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev 8, CD009603 <br> 20. Lalla RV, Bowen J (2014) Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy, Cancer <br> 21. Elad S, Or R, Shapira MY et al (2003) CO2 laser in oral graft-versus-host disease: a pilot study. Bone Marrow Transplant 32:1031鈥?034 bmt.1704272" target="_blank" title="It opens in new window">CrossRef <br> 22. Dijkstra PUSM, Pater R, Spijkervet FKL, Roodenburg JLN (2007) Exercise therapy for trismus in head and neck cancer. Oral Oncol 43:389鈥?94 blank" title="It opens in new window">CrossRef <br> 23. Coracin FL, Pizzigatti Correa ME, Camargo EE et al (2006) Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods. Bone Marrow Transplant 37:955鈥?59 bmt.1705351" target="_blank" title="It opens in new window">CrossRef <br>
- 作者单位：Leanne K. Jackson (1) (4) <br> Douglas B. Johnson (1) <br> Jeffrey A. Sosman (1) <br> Barbara A. Murphy (1) <br> Joel B. Epstein (2) (3) <br><br>1. Department of Medicine, Vanderbilt University, Nashville, TN, USA <br> 4. 9402 The Vanderbilt Clinic, Nashville, TN, 37232-5616, USA <br> 2. Oral Medicine Services, Otolaryngology and Head and Neck Surgery, City of Hope National Medical Center, Duarte, LA, USA <br> 3. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA <br>
- ISSN：1433-7339
文摘